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Background: The diagnosis of sarcoidosis requires both compatible clinical features and path-
ologic findings as a means to exclude other differential diagnoses. The utility of endobronchial
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for diagnosis of sarcoidosis
has been reported, although its indication remains unclear for cases of suspicious sarcoidosis.
To clarify the role of EBUS-TBNA for the diagnosis of sarcoidosis, we compared three diagnostic
modalities: EBUS-TBNA, transbronchial lung biopsy (TBLB) and bronchoalveolar lavage fluid
analysis (BAL).
Methods: Thirty-eight patients with suspicious sarcoidosis who had enlarged hilar and/or medi-
astinal lymph nodes on chest CT were retrospectively reviewed. Patients with malignancies or
prior established diagnosis of sarcoidosis were excluded. BAL was initially performed followed
by TBLB and finally EBUS-TBNA at the same setting. Microbacterial examinations were also per-
formed from all samples.
Results: Pathological findings compatible with sarcoidosis were obtained in 32 patients. The
remaining 6 patients were diagnosed as one case each of chronic eosinophilic pneumonia,
atypical mycobacterial infection and tuberculosis, and the remaining three were pathologi-
cally indefinite cases. Clinically, 35 patients were diagnosed with sarcoidosis. The diagnosticlavage fluid analysis; CT, computed tomography; EBUS-TBNA, endobronchial ultrasound-guided
B, transbronchial lung biopsy; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration.
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Utility of EBUS for the sarcoidosis diagnosis 1797accuracy of sarcoidosis was significantly better by EBUS-TBNA (91.4%, p< 0.001) compared to
the other two modalities. According to chest roentgenogram classifications, there were 31
stage I patients and 4 stage II patients. For stage I patients, EBUS-TBNA was significantly better
(90.3%, p< 0.001), but each modality showed 100% accuracy for stage II patients.
Conclusion: It is recommended that EBUS-TBNA is added to the conventional diagnostic modal-
ities for patients with suspicious stage I sarcoidosis on chest roentgenogram.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Sarcoidosis is a multi-system disorder of unknown etiology
that is characterized by non-caseating epithelioid cell gran-
ulomas.1 Some patients with sarcoidosis develop cardiac or
neurological dysfunctions, and 1%e5% of patients with
chronic sarcoidosis die of respiratory failure, cardiac or
neurological dysfunction.2 Systemic steroid therapy is used
for progressive patients and this therapy should only be used
based on a firm diagnosis. In addition to clinical features,
a pathological confirmation is crucial for the diagnosis of
sarcoidosis and to exclude other possible diseases.
Recently, the efficacy of endobronchial ultrasound-
guided transbronchial needle aspiration (EBUS-TBNA) for
the diagnosis of sarcoidosis has been reported.3 A dedi-
cated 22-gauge needle is used for EBUS-TBNA under local
anesthesia, which allows cytological as well as histological
evaluation of the lesion. However, there are no reports that
have compared EBUS-TBNA to conventional bronchoscopic
diagnostic modalities, such as transbronchial lung biopsy
(TBLB) and bronchoalveolar lavage fluid analysis (BAL).
Materials and methods
Patients
To identify patients for this study, we performed a retro-
spective chart review of patients who underwent EBUS-
TBNA for the period January 2004eApril 2008. Patients with
suspected or known malignancies or prior established
diagnosis of sarcoidosis were excluded. We identified 38
patients with clinical and radiological features suspicious of
sarcoidosis and the patients underwent EBUS-TBNA for the
tissue confirmation of sarcoidosis. Both chest roentgeno-
gram and computed tomography (CT) were performed prior
to bronchoscopic examination. At least 1 enlarged medi-
astinal or hilar lymphadenopathy >10 mm in the short axis
was observed in all patients. Patients were managed on an
outpatient basis, unless they were already admitted to the
hospital for other reasons. Written informed consent was
obtained from all patients included in this study.
Examination procedures
All patients received three diagnostic modalities during the
same examination: EBUS-TBNA, TBLB and BAL. All bron-
choscopic procedures were performed on an outpatient
basis under local anesthesia with mild conscious sedation.
Three milliliter of 1% lidocaine was nebulised and 5 ml of 4%
lidocaine was sprayed into the pharynx. Two milliliter of 1%lidocaine was administered through the channel during the
procedures. The bronchoscope was inserted orally during
midazolam-induced conscious sedation. Patients were
monitored by ECG, pulse oximetry and blood pressure
without the presence of an anesthesiologist. Conventional
flexible bronchoscopy (BF-240 and BF-260 bronchovideo-
scope; Olympus; Tokyo, Japan) was first used for BAL and
TBLB.
First, BAL was performed in a standard fashion (50 ml for
3 times, total 150 ml, recovery rate> 60%). Then, at least 3
biopsy specimens were obtained by TBLB by independent
pulmonologists (KK, YT). TBLB specimen was mainly
obtained from the right upper lobe under the fluoroscopy
guidance if there were no radiological findings in the lung
field (stage I). If there was evidence of pulmonary paren-
chymal involvement by chest radiographs (stage II), TBLB
specimen was obtained from targeted region. Following the
conventional bronchoscopy, EBUS-TBNA using a convex
probe endobronchial ultrasound bronchoscope (CP-EBUS;
BF-UC260F-OL8, Olympus, Tokyo, Japan) was performed
(TN, KY, TF, MC).
Diagnosis of sarcoidosis
A diagnosis of sarcoidosis was made if the clinic-radiological
findings were supported by pathological tissue demon-
strating non-caseating granulomas without necrosis or the
cytological specimen demonstrated non-caseating epithe-
lioid cells based on subsequent clinical assessments if
a negative culture result was obtained from all samples.
Other granulomatous diseases were excluded by reviewing
the patient’s history and microbiological results. Cases
were classified as ‘‘indefinite’’ if no diagnosis could be
made by pathological and biological examinations. All
patients were followed up clinically and radiologically for
more than 6 months.
EBUS-TBNA procedure
The CP-EBUS is integrated with a convex transducer (fre-
quencyZ 7.5 MHz) at the tip of a flexible bronchoscope.
The outer diameter of the insertion tube of the flexible
bronchoscope is 6.7 mm, and that of the tip was 6.9 mm.
The direction of view is 35 forward oblique. This CP-EBUS
is a linear curved array transducer that scans parallel to the
insertion direction of the bronchoscope. Images are
obtained by directly contacting the probe or by attaching
an inflated balloon filled with saline to the tip, which keeps
the probe in contact while sampling the lymph node.
The ultrasound images are processed using a dedicated
ultrasound scanner (EU-C2000; Olympus) and visualized
Table 1 Patient characteristics.
Characteristics No.
Patients 38
Male/female 11/27
Median age (range), yrs 48.2 (23e77)
Final diagnosis
Sarcoidosis 32
Chronic eosinophilic pneumonia 1
MAC 1
Tuberculosis 1
Indefinite 3
Stage
Stage I 31
Stage II 4
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image on the same monitor. This system has an integrated
power Doppler mode that allows blood vessels to be
identified and avoids inadvertent puncturing. The inner
diameter of the working channel is 2.0 mm. A dedicated 22-
gauge needle (NA-201SX-4022, Olympus) is used to perform
transbronchial needle aspiration. The inner diameter of this
needle was nearly equal to that of a conventional 21-gauge
needle, which allowed the sampling of histological cores in
some cases. The station of lymph nodes was identified
according to the International Staging System.4
Lymph node sampling
After the initial puncture, the internal sheath was used to
clean out the internal lumen, which became clogged with
bronchial membrane. The internal sheath was then
removed and negative pressure was applied with a syringe.
After the needle was moved back and forth inside the
lymph node, the needle was retrieved and the internal
sheath was used again to push out the histological core.5
With this method, histological cores as well as cytological
specimens could be obtained. The aspirated material was
smeared onto glass slides. Smears were air-dried as well as
fixed in 95% alcohol. Dried smears were evaluated by an on-
site cytopathologist to ensure that the cell material
obtained was of adequate quality. Adequate cell material
was defined as having a specific diagnosis, such as presence
of epithelioid cells without necrosis or the presence of
lymphocytes in the specimen. If adequate tissue was not
identified by on-site cytology after 3 passes, the procedure
was terminated. In addition, Papanicolaou staining and
light microscopy were done by an independent cytopa-
thologist who was blinded to the details of the cases. The
obtained histological specimens were fixed in formalin
before being sent to the pathology department. Aspirated
material was also sent for microbiological examination,
including special staining for fungi, acid-fast bacilli and
cultures for tuberculosis and fungi. In addition, PCR
examination was performed for acid-fast bacilli if needed.
Statistical analysis
The diagnostic accuracy rate was calculated using standard
definitions. The chi-square test was used for comparison of
the two modalities for the correct prediction of sarcoidosis.
Ethics committee approval
The study was approved by the ethical committee of Chiba
University, Graduate School of Medicine (No. 220) and
written consent was obtained from all patients. All authors
read and approved the final manuscript.
Results
Patient characteristics
There were 11 males and 27 females. Their average age was
48.2 years (range 22e77 years). According to the standard
scoring system for chest roentgenogram,6 31 patients (88.6%)were classified as stage I and 4 patients were stage II.
Pathological and microbiological diagnoses by all broncho-
scopic procedures were as follows: 32 cases of sarcoidosis,
one case each of chronic eosinophilic pneumonia, atypical
mycobacterial infection and tuberculosis, and 3 indefinite
cases. BAL was performed for all patients for a supporting
diagnosis and the CD4/CD8T cell ratio was evaluated. Serum
levels of angiotensin-converting enzyme (ACE) and Gallium
67 scanning were also evaluated for selected cases.7 Finally,
35 patients were clinically diagnosed with sarcoidosis.
Evaluated lymph nodes
A total of 51 lymph nodes were recorded and aspirated.
The mean size of the enlarged lymph nodes, as measured by
EBUS, was 14.8 mm (range 7.3e30.0 mm). Forty-four
(86.3%) enlarged lymph nodes were located in the medi-
astinal region and the remaining 7 lymph nodes were hilar
lymph nodes. The most commonly occurring lymph node
station was subcarinal, station 7 (28/51, 54.9%), with
a measured mean size of 16.4 mm (range 8e30 mm)
(Table 1).
Diagnostic rate
Of 35 patients, 14 (40.0%) had non-caseating granulomas by
TBLB. EBUS-TBNA revealed non-caseating granulomas or
epithelioid cells in 32 of 35 cases (91.4%; 22 non-caseating
granuloma, 25 epithelioid cells). The overall diagnostic
accuracy rate for sarcoidosis was significantly better by
EBUS-TBNA compared with TBLB (p< 0.001). A CD4/CD8
ratio> 3.5 by BAL was shown in 25 of 35 patients (65.7%).
Further analysis was performed following the standard
scoring system for chest roentgenograms. For stage I
patients, 28 of 31 patients were diagnosed with sarcoidosis
by EBUS-TBNA (90.3%, 19 non-caseating granuloma, 22
epithelioid cells), although TBLB could only diagnose 10
patients with sarcoidosis (32.3%) (Tables 2 and 3). However,
each modality had 100% accuracy for stage II patients
(Table 2). No complications were noted in this study,
including pneumothorax, pneumomediastinum or excessive
bleeding.
Table 2 Lymph node stations assessed by EBUS-TBNA.
CT EBUS
Short axis in mm (range)
Station
#4R (nZ 16) 15.2 (9e26) 14.2 (7.3e23.8)
#7 (nZ 28) 16.4 (8e30) 18.0 (10.1e30.0)
#11 (nZ 7) 13.3 (10e18) 12.3 (8.0e16.7)
Total (nZ 51) 14.9 (8e30) 14.8 (7.3e30.0)
Regional
Mediastinum (nZ 44)
Hilum (nZ 7)
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Although many of the stage I and II patients may be
asymptomatic, differential diagnosis such as tuberculosis,
other granulomatous disorders, Hodgkin lymphomas and
malignancy cannot be ruled out with certainty. Therefore,
tissue confirmation is crucial in patients with suspicious
sarcoidosis. EBUS-TBNA could diagnose sarcoidosis more
precisely, especially for stage I cases that showed hilar
adenopathies and no infiltrates on chest roentgenograms.6
We previously reported the utility of EBUS-TBNA for the
diagnosis of sarcoidosis.3 However, the indication for EBUS-
TBNA in the diagnosis of sarcoidosis has remained unclear,
as there are no reports that have compared EBUS-TBNA
with TBLB and BAL. Although this study has a limi-
tation due to the small number of patients, EBUS-TBNA is
a promising modality for the diagnoses of stage I
sarcoidosis.
The diagnosis of sarcoidosis is established when clin-
icoradiological findings are supported by histological
evidence of non-caseating epithelioid cell granulomas.Table 3 Comparison of each diagnostic modalities.
Diagnostic rate (overall)
TBLB 14/35 40.0%
EBUS-TBNA 32/35 91.4%
Cytology 25/35 71.4%
Histology 22/35 62.9%
BAL (CD4/CD8S3.5) 25/35 65.7%
Diagnostic rate (Stage I)
TBLB 10/31 32.3%
EBUS-TBNA 28/31 90.3%
Cytology 22/31 71.0%
Histology 19/31 61.3%
BAL (CD4/CD8S3.5) 19/31 61.3%
Diagnostic rate (Stage II)
TBLB 4/4 100%
EBUS-TBNA 4/4 100%
Cytology 3/4 75.0%
Histology 3/4 75.0%
BAL (CD4/CD8S3.5) 4/4 100%On the other hand, the utility of cytology in the diag-
nosis of sarcoidosis has been previously reported with
the reported sensitivity of over 90%. Granulomas of
known causes and local sarcoid reactions must be
excluded, thus we examined all aspirated materials for
microbacterial examination including special staining for
fungi, acid-fast bacilli and cultures for tuberculosis and
fungi. In addition, PCR examination was performed for
acid-fast bacilli if needed. Furthermore, we excluded
the patients with the possibility for other granulomatous
diseases such as sarcoid reactions with malignancy and
occupational disease (berylliosis) by reviewing the
patient’s history.
TBLB is the recommended procedure in most cases.
However, the diagnostic yield depends largely on the
experience of the person performing the procedure and
the number of biopsies.8 Furthermore, TBLB has a risk of
pneumothorax and haemoptysis.9 BAL fluid analysis is
also performed for sarcoidosis patients as the lympho-
cyte markers CD4 and CD8 can be used to analyze the
CD4/CD8 ratio. Although a ratio> 3.5 substantiates the
diagnosis of sarcoidosis,10 BAL is not used for patholog-
ical diagnosis.
Elevated serum ACE levels are often observed in
sarcoidosis patients.11 However, there are also elevations
of ACE levels in other granulomatous diseases, such as
tuberculosis and Gaucher’s disease.12 Gallium 67 scanning
also shows positive results in sarcoidosis patients. Typical
findings of a gallium scan (Panda sign or Lambda sign) can
support a diagnosis of sarcoidosis.13 However, these findings
are only observed in a limited proportion of patients14 and
they are not a pathological diagnosis.
By comparison, up to 90% of sarcoidosis patients
present hilar and/or mediastinal lymph node enlarge-
ments radiologically.15 Mediastinoscopy has hitherto been
the method of choice when TBLB is futile.16 However,
mediastinoscopy is invasive, carried out under general
anesthesia, costly, requires inpatient care and has
a complication rate of 2e3%.17 This has led to the search
for a less invasive tool with a high diagnostic yield and
minimal complications.
TBNA was shown to increase the diagnostic yield to 72%
for stage I sarcoidosis.18 However, TBNA is performed with
‘‘blind’’ needle aspiration guided by prior CT imaging.
Endoscopic ultrasound-guided fine needle aspiration (EUS-
FNA) is a transesophageal approach for mediastinal lymph
nodes under ultrasound guidance and the diagnostic yield is
also very high.19e21 However, EUS-FNA has a limitation in
that it can only access medastinal lymph nodes that are
adjacent to the esophagus. EUS-FNA cannot assess the hilar
lymph nodes, which are frequently enlarged in sarcoidosis
patients.19
EBUS-TBNA was first proved to be clinically useful for
evaluation of mediastinal and hilar lymph nodes under local
anesthesia and conscious sedation.22 Past reports on EBUS-
TBNA have focused on the diagnosis and staging of lung
cancer with hilar and mediastinal lymph nodes, and the
diagnostic yield is around 90%.5,23e26 Severe complications
related to EBUS-TBNA have never been reported.27
Now, we recommend that EBUS-TBNA be added to the
conventional bronchoscopic procedures when the patient
has suspected stage I sarcoidosis.
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